腹膜细胞学对低中危子宫内膜癌的预后意义
本研究为不列颠哥伦比亚癌症登记处2003至2009年接受手术及腹腔冲洗的子宫内膜样子宫内膜癌患者的回顾性人群队列研究。低危定义为IA期1或2级,中危定义为IA期3级或IB期1或2级。低中危患者中阳性腹膜细胞学与无病生存(HR 3.17,95%CI 0.91-11.03)和总生存(HR 1.33,95%CI 0.47-3.76)均无显著关联。
要点
- 低中危子宫内膜癌患者中阳性腹膜细胞学与无病生存和总生存均无显著关联。
- 仅年龄和广泛淋巴血管间隙浸润(LVSI)与较低总生存相关(HR 1.10,95%CI 1.08-1.13;HR 2.39,95%CI 1.02-5.61)。
- 849例患者中49例(5.8%)腹膜细胞学阳性,低危和中危分别有6例和9例。
核心结论
- 低中危子宫内膜癌患者中阳性腹膜细胞学与无病生存和总生存均无显著关联。
研究设计与样本
- 回顾性人群队列研究,纳入不列颠哥伦比亚癌症登记处2003至2009年接受手术及腹腔冲洗的子宫内膜样子宫内膜癌患者849例。
- 低危定义为IA期1或2级,中危定义为IA期3级或IB期1或2级;低危370例(43.6%),中危298例(35.1%)。
主要发现
- 总体49例(5.8%)腹膜细胞学阳性,低危和中危分别有6例和9例(低中危合计2.2%)。
- 低中危患者中阳性腹膜细胞学与无病生存无显著关联(HR 3.17,95%CI 0.91-11.03)。
- 低中危患者中阳性腹膜细胞学与总生存无显著关联(HR 1.33,95%CI 0.47-3.76)。
- 仅年龄和广泛LVSI与较低总生存相关(HR 1.10,95%CI 1.08-1.13;HR 2.39,95%CI 1.02-5.61)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: There is uncertainty surrounding the prognostic value and clinical utility of peritoneal cytology in endometrial cancer. Our primary objective was to determine if positive cytology is associated with disease-free and overall survival in women treated surgically for endometrial cancer, specifically those with low or intermediate risk disease. METHODS: This was a retrospective population-based cohort study of British Columbia Cancer Registry patients who underwent surgery with peritoneal washings for endometrioid-type endometrial cancer from 2003 to 2009. Low risk was defined as Stage IA grade 1 or 2, and intermediate risk defined as Stage IA grade 3, or Stage IB grade 1 or 2 tumours. Five-year overall and disease free-survival were assessed using Kaplan-Meier estimation. Potential covariates including peritoneal cytology, grade, depth of myometrial invasion, LVSI, age, and adjuvant therapy were evaluated in a multivariable Cox proportional hazards model. RESULTS: There were 849 patients, of whom 370 (43.6%) and 298 (35.1%) had low- and intermediate-risk disease, respectively. Overall, forty-nine (5.8%) patients had positive cytology, including 6 and 9 with low- and intermediate-risk respectively (2.2% within low and intermediate risk combined). Positive peritoneal cytology was not significantly associated with disease-free (HR 3.17, 95% CI 0.91-11.03) or overall survival (HR 1.33, 95% CI 0.47-3.76) in low and intermediate risk patients. Only age and extensive LVSI were associated with lower overall survival (HR 1.10, 95% CI 1.08-1.13, and HR 2.39, 95% CI 1.02-5.61, respectively). CONCLUSIONS: Positive peritoneal cytology was not associated with disease-free and overall survival in women with low and intermediate risk endometrial cancer.
引用
- Scott SA, van der Zanden C, Cai E, et al. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer. Gynecol Oncol. 2017. PMID: 28359690. doi:10.1016/j.ygyno.2017.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。